{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T16:25:31Z","timestamp":1769271931079,"version":"3.49.0"},"reference-count":23,"publisher":"Elsevier BV","issue":"22","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,4,17]],"date-time":"2019-04-17T00:00:00Z","timestamp":1555459200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100014588","name":"Sanofi Pasteur","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014588","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1016\/j.vaccine.2019.04.035","type":"journal-article","created":{"date-parts":[[2019,4,19]],"date-time":"2019-04-19T07:56:52Z","timestamp":1555660612000},"page":"2960-2966","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["An in vitro functional assay to measure the biological activity of TB vaccine candidate H4-IC31"],"prefix":"10.1016","volume":"37","author":[{"given":"Marin","family":"Ming","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lidice","family":"Bernardo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kimberley","family":"Williams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pappachan","family":"Kolattukudy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nidhi","family":"Kapoor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leslie G.","family":"Chan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anke","family":"Pagnon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabienne","family":"Piras","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin","family":"Su","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beata","family":"Gajewska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danielle","family":"Salha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucy","family":"Gisonni-Lex","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.vaccine.2019.04.035_b0005","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1586\/14760584.6.3.441","article-title":"Next generation: tuberculosis vaccines that elicit protective CD8+ T cells","volume":"6","author":"Behar","year":"2007","journal-title":"Expert Rev Vacc"},{"issue":"6","key":"10.1016\/j.vaccine.2019.04.035_b0010","doi-asserted-by":"crossref","first-page":"e39909","DOI":"10.1371\/journal.pone.0039909","article-title":"The HyVac4 subunit vaccine efficiently boosts BCG-primed anti-mycobacterial protective immunity","volume":"7","author":"Billeskov","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2019.04.035_b0015","unstructured":"Food and Drug Administration (FDA) CFR Code of Federal Regulations, Title 21, Volume 7, 2016. 21CFR600.3"},{"key":"10.1016\/j.vaccine.2019.04.035_b0020","unstructured":"ICH 1999 International conference on harmonization of technical requirements for registration of pharmaceuticals for human use. Specifications: Test Procedures and Acceptance Criteria for Biotechnological\/Biological Products. Q6B."},{"issue":"4","key":"10.1016\/j.vaccine.2019.04.035_b0025","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1128\/IAI.01009-16","article-title":"Characterization of T Cells specific for CFP-10 and ESAT-6 in mycobacterium tuberculosis-infected Mauritian cynomolgus macaques","volume":"85","author":"Ellis","year":"2017","journal-title":"Infect Immun"},{"issue":"1","key":"10.1016\/j.vaccine.2019.04.035_b0030","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1128\/CVI.00208-09","article-title":"Peptide microarray-based identification of mycobacterium tuberculosis epitope binding to HLA-DRB1*0101, DRB1*1501, and DRB1*0401","volume":"17","author":"Gaseitsiwe","year":"2010","journal-title":"Clin Vacc Immunol"},{"issue":"30","key":"10.1016\/j.vaccine.2019.04.035_b0035","doi-asserted-by":"crossref","first-page":"3592","DOI":"10.1016\/j.vaccine.2015.05.036","article-title":"The tuberculosis vaccine H4:IC31 is safe and induces a persistent polyfunctional CD4 T cell response in South African adults: a randomized controlled trial","volume":"33","author":"Geldenhuys","year":"2015","journal-title":"Vaccine"},{"issue":"7661","key":"10.1016\/j.vaccine.2019.04.035_b0040","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/nature22976","article-title":"Identifying specificity groups in the T cell receptor repertoire","volume":"547","author":"Glanville","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2019.04.035_b0045","unstructured":"http:\/\/www.aeras.org\/pages\/global-portfolio Global Clinical Portfolio of TB Vaccine Candidates, Aeras. Access date: 17Apr2018."},{"issue":"12","key":"10.1016\/j.vaccine.2019.04.035_b0050","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1093\/infdis\/jiw467","article-title":"Induction of an immune-protective T-cell repertoire with diverse genetic coverage by a novel viral-vectored tuberculosis vaccine in humans","volume":"214","author":"Jeyanathan","year":"2016","journal-title":"J Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2019.04.035_b0055","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0053657","article-title":"Human granuloma in vitro model, for TB dormancy and resuscitation","volume":"8","author":"Kapoor","year":"2013","journal-title":"PLoS ONE"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2019.04.035_b0060","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jchromb.2005.06.013","article-title":"Separation and quantification of a novel two-component vaccine adjuvant","volume":"822","author":"Kritsch","year":"2005","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"issue":"7","key":"10.1016\/j.vaccine.2019.04.035_b0065","first-page":"13","article-title":"A quantitative analysis of complexity of human pathogen-specific CD4 T cell responses in healthy M. tuberculosis infected South Africans","volume":"12","author":"Lindestam","year":"2016","journal-title":"PLoS Pathog"},{"issue":"21\u201322","key":"10.1016\/j.vaccine.2019.04.035_b0070","doi-asserted-by":"crossref","first-page":"2843","DOI":"10.1016\/j.vaccine.2003.12.027","article-title":"Development of an in vitro-based potency assay for anthrax vaccine","volume":"22","author":"Little","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.04.035_b0075","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.provac.2011.10.002","article-title":"Non-animal replacement methods for human vaccine potency testing: state of the science and future directions","volume":"5","author":"McFarland","year":"2011","journal-title":"Procedia Vaccinol"},{"issue":"6","key":"10.1016\/j.vaccine.2019.04.035_b0080","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/j.tube.2015.07.005","article-title":"The TB-specific CD4(+) T cell immune repertoire in both cynomolgus and rhesus macaques largely overlap with humans","volume":"95","author":"Moth\u00e9","year":"2015","journal-title":"Tuberculosis (Edinb)"},{"issue":"2","key":"10.1016\/j.vaccine.2019.04.035_b0085","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1056\/NEJMoa1714021","article-title":"C-040-404 study team. Prevention of M. tuberculosis infection with H4:IC31 vaccine or BCG revaccination","volume":"379","author":"Nemes","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2019.04.035_b0090","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1016\/j.vaccine.2017.01.055","article-title":"Safety and immunogenicity of the novel H4:IC31 tuberculosis vaccine candidate in BCG-vaccinated adults: two phase I dose escalation trials","volume":"35","author":"Norrby","year":"2017","journal-title":"Vaccine"},{"issue":"7","key":"10.1016\/j.vaccine.2019.04.035_b0095","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1128\/CVI.00131-10","article-title":"Correlates of protection induced by vaccination","volume":"17","author":"Plotkin","year":"2010","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2019.04.035_b0100","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1038\/35021239","article-title":"Vaccines against intracellular infections requiring cellular immunity","volume":"406","author":"Seder","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2019.04.035_b0105","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/nri2274","article-title":"T-cell quality in memory and protection: implications for vaccine design","volume":"8","author":"Seder","year":"2008","journal-title":"Nat Rev Immunol"},{"issue":"9","key":"10.1016\/j.vaccine.2019.04.035_b0110","doi-asserted-by":"crossref","first-page":"4665","DOI":"10.4049\/jimmunol.154.9.4665","article-title":"Mapping of T cell epitopes of the 30-kDa alpha antigen of Mycobacterium bovis strain bacillus Calmette-Gu\u00e9rin in purified protein derivative (PPD)-positive individuals","volume":"154","author":"Silver","year":"1995","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2019.04.035_b0115","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s41479-016-0020-z","article-title":"Novel vaccination approaches to prevent tuberculosis in children","volume":"8","author":"Triccas","year":"2016","journal-title":"Pneumonia (Nathan)"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19304864?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19304864?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:32:14Z","timestamp":1759401134000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X19304864"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":23,"journal-issue":{"issue":"22","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["S0264410X19304864"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.04.035","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An in vitro functional assay to measure the biological activity of TB vaccine candidate H4-IC31","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.04.035","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}